In breast cancer, upregulation of FTO downregulates the m6A epigenetic modification and decreases the expression of BCL2-interacting protein 3 (BNIP3), which is dependent on YTHDF2, a proapoptotic protein. The gene discussed is BNIP3; the disease is breast carcinoma.